Mednet Logo
HomeRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

Would you offer neoadjuvant chemotherapy prior to trimodality therapy in a fit patient who refuses surgery for muscle-invasive bladder cancer?

1
1 Answers

Mednet Member
Mednet Member
Medical Oncology · Mayo Clinic

Unfortunately, this is a question without a clear answer at this time. Trimodality therapy, consisting of maximal TURBT, chemotherapy, and radiation, appears to have equivalent outcomes and has NCCN Category 1 recommendations for patients with MIBC. We do not routinely do neoadjuvant chemotherapy fo...

How do you treat a patient with early-stage breast cancer s/p lumpectomy and oncoplastic reconstruction with a positive margin, when re-excision is not feasible?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

It depends on the level of oncoplastic surgery done. If level 1, we can identify the surgical site and can boost after whole-breast RT of 26 in 5 or 40 in 15. If level 2 or 3, then just increase the whole breast dose to 42.5 in 16, as we can’t identify the boost area.Han et al., PMID 40024440

Are you offering Lutathera for multiple recurrent meningiomas?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Arizona

Lutathera is currently only FDA-approved for treating somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs). However, research is ongoing to explore its potential use for meningiomas, as many meningiomas express somatostatin receptors, which could make it a promising...

What dose constraints do you use for 60 Gy in 15-20 fraction lung treatments that are adjacent to the hilum?

8
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Toronto

The LUSTRE trial, which is a Canadian RCT comparing SABR (60/8, 48/4) vs. 60/15 provides some max point constraints to address this for 15#. Swaminath, Clin Lung Cancer. 2017 Mar;18(2):250-254. Spinal Canal 36 GyEsophagus 48 GyBrachial Plexus 50 GyHeart 66 GyGreat Vessels 66 GyTrachea/PBT 66 GySkin ...

What is the optimal interval between vaginal cuff brachytherapy sessions?

2
5 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Texas MD Anderson Cancer Center

At MD Anderson, we give 6 Gy x 5 to the surface and we most often treat every other day. However, given the low risk of toxicity, we think it's safe to make adjustments to this schedule. For example, we often do some treatments on sequential days if that's preferred for any reason. We also schedule ...

How do you manage a prostate cancer patient with pelvic lymphadenopathy and a single enlarged PSMA PET+ gastrohepatic node?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Allegheny Health Network

I would treat it as oligometastatic, starting with ADT/ARPI and use metastasis-directed therapy and pelvic radiation.

Are you offering hypofractionated comprehensive nodal irradiation following neoadjuvant chemotherapy for patients with locally advanced breast cancer in the setting of COVID-19?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Allegheny Health Network, Pittsburgh

In locally advanced breast cancer following neoadjuvant chemotherapy, we are offering hypofractionated radiation to the breast and regional nodes, and flat chest wall and regional nodes. In these cases, I treat to 40 Gy/15 fractions. For nodal coverage, I like to see 38 Gy line covering nodal basins...

Do you consider increased tumor thickness alone as an indication for postoperative radiation in oral cavity cancers?

7
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Texas MD Anderson Cancer Center

Depth of invasion (DOI )has been shown to predict regional disease. As such, surgeons will use this information to decide if a neck dissection (ND) should be performed in the cN0 patient with oral tongue cancer.With no other adverse features (i.e., no PNI, no LVSI, no poor differentiation, good marg...

In ES-SCLC presenting with extensive brain metastases, how do you time whole brain radiation after the first cycle of chemotherapy has already been delivered?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Yale School of Medicine

We typically try to wait as long as possible before we start WBRT. It depends on the burden and symptomatology of intracranial disease as well as the initial response to chemo-immunotherapy. If the brain metastases are asymptomatic and deemed OK to monitor closely (i.e., not likely to cause neurolog...

Would you treat a patient with an N2 ipsilateral recurrence following re-resection of bronchial stump recurrence?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Dartmouth-Hitchcock Medical Center

My answer is predicated on the assumption that this patient has not had prior radiation therapy. If that is the case, then I would treat them. It is important to talk to the thoracic surgeon and know how the bronchial stump was "finished". My preference is that it is done with a fresh intercostal mu...